Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NADclinic Group is a global health and wellness company specializing in the delivery of Nicotinamide Adenine Dinucleotide (NAD+) therapies. Based in London's Harley Street, the company offers a comprehensive suite of services including proprietary IV infusion protocols, diagnostic testing, and specialized nutraceuticals. Their clinical programs are designed to address cellular aging, metabolic dysfunction, chronic fatigue, and addiction recovery. NADclinic operates an international network of partner clinics and provides medical-grade NAD+ formulations to healthcare providers globally. The company focuses on the intersection of longevity science and personalized medicine to optimize human performance and healthspan.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NADclinic Group.